CB<sub>1</sub>-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32902378.
- Also identified by DOI 10.7554/eLife.54812 and PMC identifier 7521925.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Long-lasting forms of postsynaptic plasticity commonly involve protein synthesis-dependent structural changes of dendritic spines. However, the relationship between protein synthesis and presynaptic structural plasticity remains unclear. Here, we investigated structural changes in cannabinoid-receptor 1 (CB<sub>1</sub>)-mediated long-term depression of inhibitory transmission (iLTD), a form of presynaptic plasticity that involves a protein-synthesis-dependent long-lasting reduction in GABA release. We found that CB<sub>1</sub>-iLTD in acute rat hippocampal slices was associated with protein synthesis-dependent presynaptic structural changes. Using proteomics, we determined that CB<sub>1</sub> activation in hippocampal neurons resulted in increased ribosomal proteins and initiation factors, but decreased levels of proteins involved in regulation of the actin cytoskeleton, such as ARPC2 and WASF1/WAVE1, and presynaptic release. Moreover, while CB<sub>1</sub>-iLTD increased ubiquitin/proteasome activity, ubiquitination but not proteasomal degradation was critical for structural and functional presynaptic CB<sub>1</sub>-iLTD. Thus, CB<sub>1</sub>-iLTD relies on both protein synthesis and ubiquitination to elicit structural changes that underlie long-term reduction of GABA release.
Medical subject headings
- Long-Term Synaptic Depression
- Protein Biosynthesis
- Receptor, Cannabinoid, CB1
- Ubiquitination